Through the use of specific tests, doctors were able to determine the type of parasites that were attacking the patient—tests typically processed through hospital lab testing facilities or specialized diagnostic labs.
Unfortunately, the antiparasitic drugs weren’t effective, sparking questions about pharmaceutical resistance, treatment efficacy, and even prescription liability frameworks.
The anti-epilepsy drugs also were unable to produce a desirable effect, a heartbreaking end for a young man who, in a different scenario, might have benefited from chronic illness insurance or wellness-based preventive diagnostics.
